§ BIOTECHNOLOGY
USD · Biotechnology

ANAB

ANAPTYSBIO INC
USDSector · BiotechnologyBeta · 0.87
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
122 increased/new, 67 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B36.07EPS (TTM)-0.88
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
EcoR1 Capital, LLC7.9M18.5%±0%
BlackRock1.7M0.0%−3%
TANG CAPITAL MANAGEMENT LLC1.3M3.7%−0%
Morgan Stanley994K0.0%n/a
State Street992K0.0%−6%
Affinity Asset Advisors, LLC940K2.7%+111%
◇ AC INTELLIGENCE

Top institutional owners for ANAB as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER66.7% · 138 holders
DEALER / BANK12.4% · 20 holders
PASSIVE / INDEX9.0% · 9 holders
QUALITY / COMPOUNDER5.3% · 13 holders
SYSTEMATIC / QUANT3.5% · 9 holders
TACTICAL / MACRO2.5% · 4 holders
ACTIVIST2.0% · 1 holder
INCOME / DEFENSIVE1.0% · 12 holders
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for ANAB in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention ANAB yet.